期刊文献+

全反式维甲酸对肝癌细胞HepG2的分化、侵袭迁移的影响 被引量:4

Effect of all-trans retinoic acid on the differentiation, invasion and metastasis of liver cancer HepG2 cells
下载PDF
导出
摘要 目的:探讨全反式维甲酸(ATRA)对肝癌细胞HepG2的诱导分化作用及侵袭迁移的影响.方法:MTT法测定ATRA对肝癌细胞HepG2的抑制作用;平皿集落形成法检测ATRA对HepG2细胞锚定依赖性生长作用;ELISA法检测ATRA作用前后HepG2 AFP分泌量的变化;RT-PCR检测ATRA对HepG2细胞MMP-9及Nanog的mRNA表达的影响;Western blot检测ATRA对HepG2细胞MMP-9及Nanog蛋白表达的影响;Transwell及划痕实验检测其对侵袭及迁移能力的影响.结果:MTT法显示ATRA抑制体外培养人肝癌细胞HepG2细胞生长,呈剂量和时间依赖性;ELISA显示ATRA诱导HepG2细胞分化和凋亡,使代表肝细胞恶变的AFP分泌量明显下降(P<0.05);平皿克隆形成实验结果表明未经ATRA处理的HepG2可形成克隆,但经ATRA刺激后,其形成克隆变小且数目明显减少;ATRA呈时间及浓度依赖性下调Nanog mRNA及蛋白的表达,并在24h呈浓度依赖性下调MMP-9 mRNA及蛋白表达;Transwell实验和划痕实验结果显示ATRA能抑制HepG2细胞的侵袭和迁移能力.结论:ATRA可诱导HepG2细胞分化,降低HepG2的侵袭迁移能力,并可下调肿瘤干细胞分化调节基因Nanog的表达从而达到治疗肿瘤的目的. AIM: To investigate the effect of all-trans retinoic acid (ATRA) on the differentiation, invasion and metastasis of liver cancer HepG2 cells. METHODS: After HepG2 cells were treated with different concentrations of ATRA, the proliferation of HepG2 cells was evaluated by MTT assay; anchorage-dependent growth was evaluated by colony formation assay; AFP secretion was determined by ELISA; the transcription levels of Nanog and MMP-9 were assessed by RT-PCR, and their protein levels were assessed by Western blot; and cell invasion and migration were evaluated by scratch test and transwell assay. RESULTS: ATRA suppressed the proliferation and anchorage-dependent growth of HepG2 in a doseand time-dependent manner. ATRA induced cell differentiation and decreased AFP secretion in HepG2 cells (both P 0.05). Treatment with ATRA down-regulated the mRNA andprotein levels of Nanog and MMP-9 (within 24 hours) in a doseand time-dependent manner. In addition, ATRA could inhibit the invasion and metastasis of HepG2 cells. CONCLUSION: ATRA may induce cell differentiation, reduce cell invasion and migration and down-regulate the levels of Nanog in HepG2 cells.
作者 陈宏辉 彭蕾
出处 《世界华人消化杂志》 CAS 北大核心 2011年第33期3381-3389,共9页 World Chinese Journal of Digestology
关键词 全反式维甲酸 肝癌 增殖 分化 侵袭 迁移 All-trans retinoic acid Liver cancer Proliferation Differentiation Invasion Migration
  • 相关文献

参考文献4

二级参考文献45

  • 1Schafer DF,Sorrell MF.Hepatocellular carcinoma. Lancet,The . 1999
  • 2Kazumasa Hiroishi,Junichi Eguchi,Toshiyuki Baba,Tomoe Shimazaki,Shigeaki Ishii,Ayako Hiraide,Masashi Sakaki,Hiroyoshi Doi,Shojiro Uozumi,Risa Omori,Takuya Matsumura,Tatsuro Yanagawa,Takayoshi Ito,Michio Imawari.Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma[J]. Journal of Gastroenterology . 2010 (4)
  • 3Lisa H. Butterfield,Antoni Ribas,Douglas M. Potter,James S. Economou.Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer[J]. Cancer Immunology, Immunotherapy . 2007 (12)
  • 4Mizejewski Gj.Physiology of alpha-fetoprotein as a bio- marker for perinatal distress:relevance to adverse preg- nancy outcome. Experimental Biology and Medicine . 2007
  • 5Liu Y,Daley S,Evdokimova VN,Zdobinski DD,Potter DM.Butterf ield LH:Hierarchy of alpha fetoprotein (AFP)-specif icT cell responses in subjects with AFP-positive hepatocellular cancer. J Immunol . 2006
  • 6Alisa A,Ives A,Pathan AA,Navarrete CV,Williams R,Ber- toletti A,Behboudi S.Analysis of CD4+ T-Cell Responses to a Novel {alpha}-Fetoprotein-Derived Epitope in Hepatocel- lular Carcinoma Patients. Clinical Cancer Research . 2005
  • 7Thimme R,Neagu M,Boettler T,Neumann-Haefelin C,Kersting N,Geissler M,Makowiec F,Obermaier R,Hopt UT,Blum HE,Spangenberg HC.Comprehensive analysis of the alpha-fetoprotein-specif ic CD8+ T cell responses in patients with hepatocellular carcinoma. Hepatology . 2008
  • 8Behboudi S,Alisa A,Boswell S,Anastassiou J,Pathan AA,Williams R.Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of dis- ease. British Journal of Cancer . 2010
  • 9Bricard G,Bouzourene H,Martinet O,Rimoldi D,Halkic N,Gillet M,Chaubert P,Macdonald HR,Romero P,Cerottini JC,Speiser DE.Naturally acquired MAGE-A10- and SSX-2-specif ic CD8+ T cell responses in patients with hepatocel- lular carcinoma. J Immunol . 2005
  • 10Matsuzaki J,Gnjatic S,Mhawech-Fauceglia P,Beck A,Miller A,Tsuji T,Eppolito C,Qian F,Lele S,Shrikant P,Old LJ,Odunsi K.Tumor-infi ltrating NY-ESO-1-specif ic CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America . 2010

共引文献64

同被引文献42

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部